Bionomics Limited : BNC105 RENAL CANCER TRIAL DATA PRESENTED AT ASCO-GU - 4-traders (press release) PDF Print
4-traders (press release)
Bionomics Limited (ASX: BNO) (ADR: BMICY) announced that BNC105 clinical trial data in patients with progressive metastatic renal cancer will be presented at the American Society for Clinical Oncology 2012 Genitourinary Cancers Symposium meeting

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129